| Literature DB >> 23554741 |
Yang Xu1, Bingrong Zhou, Di Wu, Zhiqiang Yin, Dan Luo.
Abstract
This study aimed to evaluate the effects of baicalin on ultraviolet radiation B (UVB)-mediated microRNA (miRNA) expression in mouse skin. We determined miRNA expression profiles in UVB irradiated mice, baicalin treated irradiated mice, and untreated mice, and conducted TargetScan and Gene Ontology analyses to predict miRNA targets. Three miRNAs (mmu-miR-125a-5p, mmu-miR-146a, and mmu-miR-141) were downregulated and another three (mmu-miR-188-5p, mmu-miR-223 and mmu-miR-22) were upregulated in UVB irradiated mice compared with untreated mice. Additionally, these miRNAs were predicted to be related to photocarcinogenesis, hypomethylation and apoptosis. Three miRNAs (mmu-miR-378, mmu-miR-199a-3p and mmu-miR-181b) were downregulated and one (mmu-miR-23a) was upregulated in baicalin treated mice compared with UVB irradiated mice, and they were predicted to be related to DNA repair signaling pathway. These deregulated miRNAs are potentially involved in the pathogenesis of photodamage, and may aid treatment and prevention of UVB-induced dermatoses.Entities:
Keywords: baicalin; microRNA; microarray; photodamage; ultraviolet radiation B
Year: 2012 PMID: 23554741 PMCID: PMC3597329 DOI: 10.1016/S1674-8301(12)60022-0
Source DB: PubMed Journal: J Biomed Res ISSN: 1674-8301
Fig. 1Effects of baicalin on UVB mediated induction of epidermal cyclobutane pyrimidine dimers (CPDs) in mouse skin.
From skin biopsies, 6 µm thick sections were cut and the effects of treatments on CPDs were assessed by immunohistochemical analysis. Representative pictures are shown. Details of experiments are provided in the text. A: UVB for 1 h. B: UVB for 24 h. C: Baicalin+UVB for 1 h. D: Baicalin+UVB for 24 h. E. Statistical analysis shows fewer remaining CPDs in the baicalin treated irradiated group than that in the UVB group.
Fig. 2qRT-PCR analysis of miRNA expression.
Plots depict the relative change in fluorescence (ΔRn) indicative of product accumulation over 40 cycles of PCR amplification using primer sets specific for the indicated miRNA sequences. PCR reactions were performed in triplicate using cDNA products derived from the indicated groups. In addition, mmu-Actin RNA was similarly analyzed as an internal reference. A: mmu-miR-223. B: mmu-miR-23a. C: mmu-miR-141. D: mmu-miR-181b. E: mmu-Actin.
Fig. 3qRT-PCR analysis of selected miRNA expression.
The figure shows that mmu-miR-23a is highly expressed in the baicalin plus UVB group compared with the UVB group, and mmu-miR-223 is increased by more than ten fold in UVB treated skin compared with control.
Differentially expressed miRNAs and their putative targets
| Results | MiRNA | Published targets | Putative targets |
| Three upregulated miRNAs in the UVB group versus the control group | mmu-miR-188-5p | ||
| mmu-miR-223 | |||
| mmu-miR-22 | |||
| Three downregulated miRNAs in the UVB group versus the control group | mmu-miR-125a-5p | ||
| mmu-miR-146a | |||
| mmu-miR-141 | |||
| One upregulated miRNA in the bcaicalin + UVB group versus the UVB group | mmu-miR-23a | ||
| Three downregulated miRNAs in the baicalin + UVB group versus UVB group | mmu-miR-378* | ||
| mmu-miR-199a-3p | |||
| mmu-miR-181b |
Gene Ontology (GO) terms for the target genes of treatment responsive miRNAs
| Results | GO term | Function | |
| Three upregulated miRNAs in the UVB group versus the control group | GO:0043283 | Biopolymer metabolic process | 3.64E-18 |
| GO:0050794 | Regulation of cellular process | 3.64E-18 | |
| GO:0050789 | Regulation of biological process | 3.56E-17 | |
| GO:0065007 | Biological regulation | 3.56E-17 | |
| GO:0031323 | Regulation of cellular metabolic process | 4.37E-15 | |
| Three downregulated miRNAs in the UVB group versus the control group | GO:0043283 | Biopolymer metabolic process | 9.13E-16 |
| GO:0050789 | Regulation of biological process | 3.06E-13 | |
| GO:0005515 | Protein binding | 3.06E-13 | |
| GO:0050794 | Regulation of cellular process | 3.06E-13 | |
| GO:0010468 | Regulation of gene expression | 3.06E-13 | |
| One upregulated miRNA in the bcaicalin + UVB group versus the UVB group | GO:0043283 | Biopolymer metabolic process | 6.10E-19 |
| GO: 0003 700 | Transcription factor activity | 1.49E-16 | |
| GO:0050794 | Regulation of cellular process | 1.64E-14 | |
| GO: 0006355 | Regulation of transcription, DNA-dependent | 1.81E-14 | |
| GO: 0006351 | Transcription, DNA-dependent | 1.81E-14 | |
| Three downregulated miRNAs in the baicalin + UVB group versus UVB group | GO:0010468 | Regulation of gene expression | 9.13E-16 |
| GO: 0045449 | Regulation of transcription | 3.06E-13 | |
| GO: 0006355 | Regulation of transcription, DNA-dependent | 3.06E-13 | |
| GO:0031323 | Regulation of cellular metabolic process | 3.06E-13 | |
| GO:0019219 | Regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 3.06E-13 |
Pathway analysis of target genes of treatment responsive miRNAs using DAVID Bioinformatics Resources 2008
| Results | KEGG pathway | -ln( |
| Three upregulated miRNAs in the UVB group versus the control group | ErbB signaling pathway | 9.45 |
| MAPK signaling pathway | 8.01 | |
| Dorsoventral axis formation | 6.67 | |
| Prostate cancer | 6.53 | |
| Chronic myeloid leukemia | 5.94 | |
| Three downregulated miRNAs in the UVB group versus the control group | Chronic myeloid leukemia | 13.54 |
| Notch signaling pathway | 9.32 | |
| Dorsoventral axis formation | 7.83 | |
| MAPK signaling pathway | 6.29 | |
| Pancreatic cancer | 5.67 | |
| One upregulated miRNA in the bcaicalin + UVB group versus the UVB group | Renal cell carcinoma | 17.12 |
| Tight junction | 14.58 | |
| Focal adhesion | 8.74 | |
| MAPK signaling pathway | 8.18 | |
| ErbB signaling pathway | 7.4 | |
| Three downregulated miRNAs in the baicalin + UVB group versus UVB group | Dorsoventral axis formation | 18.09 |
| Glioma | 14.46 | |
| Renal cell carcinoma | 12.22 | |
| Long term potentiation | 10.97 | |
| MAPK signaling pathway | 10.92 |